More from the company: RhoVac"s evenemang under januari - mars 2020

Press release from Companies: RhoVac erhåller godkännande i Belgien och Tyskland för start av klinisk fas IIb-studie

Press release from Companies: RhoVac receives approval in Germany and Belgium to start clinical phase IIb study in prostate cancer

Press release from Companies: RhoVac rekryterar Steffen Wad Jørgensen som utvecklingschef

Press release from Companies: RhoVac recruits Steffen Wad Jørgensen as Chief Development Officer

Press release from Companies: RhoVac avslutar samarbetet med Colpman Consulting Ltd

Press release from Companies: RhoVac ends the collaboration with Colpman Consulting Ltd

Press release from Companies: RhoVac rapporterar delresultat om immunologiskt svar med RV001

Press release from Companies: RhoVac reports interim results on immunological response with RV001

Reports: RhoVac AB presenterar delårsrapport Q3 2019

Press release from Companies: Första patient screenad till RhoVacs kliniska fasIIb-studie

Press release from Companies: First patient screened for RhoVac"s clinical phase IIb-study